JP2009514906A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009514906A5 JP2009514906A5 JP2008539289A JP2008539289A JP2009514906A5 JP 2009514906 A5 JP2009514906 A5 JP 2009514906A5 JP 2008539289 A JP2008539289 A JP 2008539289A JP 2008539289 A JP2008539289 A JP 2008539289A JP 2009514906 A5 JP2009514906 A5 JP 2009514906A5
- Authority
- JP
- Japan
- Prior art keywords
- tyr
- group
- phe
- unsaturated
- pro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920006395 saturated elastomer Polymers 0.000 claims description 24
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 16
- 125000004432 carbon atom Chemical group C* 0.000 claims description 14
- 125000002252 acyl group Chemical group 0.000 claims description 13
- 102000015636 Oligopeptides Human genes 0.000 claims description 11
- 108010038807 Oligopeptides Proteins 0.000 claims description 11
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 9
- 229930182558 Sterol Natural products 0.000 claims description 8
- 125000005647 linker group Chemical group 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- 125000002544 sphingolipid group Chemical group 0.000 claims description 8
- 150000003432 sterols Chemical class 0.000 claims description 8
- 235000003702 sterols Nutrition 0.000 claims description 8
- 239000002537 cosmetic Substances 0.000 claims description 6
- 229940061720 alpha hydroxy acid Drugs 0.000 claims description 2
- 150000001280 alpha hydroxy acids Chemical class 0.000 claims description 2
- 150000001277 beta hydroxy acids Chemical class 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 230000037307 sensitive skin Effects 0.000 claims description 2
- 125000004429 atom Chemical group 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 239000002280 amphoteric surfactant Substances 0.000 description 4
- 230000001588 bifunctional effect Effects 0.000 description 4
- 239000002253 acid Substances 0.000 description 3
- -1 acyl sarcosine Chemical compound 0.000 description 3
- ARIWANIATODDMH-AWEZNQCLSA-N 1-lauroyl-sn-glycerol Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)CO ARIWANIATODDMH-AWEZNQCLSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- ARIWANIATODDMH-UHFFFAOYSA-N Lauric acid monoglyceride Natural products CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 description 2
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- ICUTUKXCWQYESQ-UHFFFAOYSA-N triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- CRDAMVZIKSXKFV-FBXUGWQNSA-N (2-cis,6-cis)-farnesol Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C/CO CRDAMVZIKSXKFV-FBXUGWQNSA-N 0.000 description 1
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 description 1
- NCKMMSIFQUPKCK-UHFFFAOYSA-N 2-benzyl-4-chlorophenol Chemical compound OC1=CC=C(Cl)C=C1CC1=CC=CC=C1 NCKMMSIFQUPKCK-UHFFFAOYSA-N 0.000 description 1
- AWDSLMQQQKGDSD-UHFFFAOYSA-N 2-hydroxy-n-octylbenzamide Chemical compound CCCCCCCCNC(=O)C1=CC=CC=C1O AWDSLMQQQKGDSD-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- 229940099451 3-iodo-2-propynylbutylcarbamate Drugs 0.000 description 1
- WYVVKGNFXHOCQV-UHFFFAOYSA-N 3-iodoprop-2-yn-1-yl butylcarbamate Chemical compound CCCCNC(=O)OCC#CI WYVVKGNFXHOCQV-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- OSDLLIBGSJNGJE-UHFFFAOYSA-N 4-chloro-3,5-dimethylphenol Chemical compound CC1=CC(O)=CC(C)=C1Cl OSDLLIBGSJNGJE-UHFFFAOYSA-N 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
- LKUNXBRZDFMZOK-GFCCVEGCSA-N Capric acid monoglyceride Natural products CCCCCCCCCC(=O)OC[C@H](O)CO LKUNXBRZDFMZOK-GFCCVEGCSA-N 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Natural products NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N N-methylaminoacetic acid Natural products C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- MXOAEAUPQDYUQM-UHFFFAOYSA-N chlorphenesin Chemical compound OCC(O)COC1=CC=C(Cl)C=C1 MXOAEAUPQDYUQM-UHFFFAOYSA-N 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229940043259 farnesol Drugs 0.000 description 1
- 229930002886 farnesol Natural products 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- AUYPHISUPZUIJS-UHFFFAOYSA-N n-decyl-2-hydroxybenzamide Chemical compound CCCCCCCCCCNC(=O)C1=CC=CC=C1O AUYPHISUPZUIJS-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229940060184 oil ingredients Drugs 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- LKUNXBRZDFMZOK-UHFFFAOYSA-N rac-1-monodecanoylglycerol Chemical compound CCCCCCCCCC(=O)OCC(O)CO LKUNXBRZDFMZOK-UHFFFAOYSA-N 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000010678 thyme oil Substances 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05023954A EP1782819A1 (en) | 2005-11-03 | 2005-11-03 | Oligopeptides and their use |
| EP05023954.0 | 2005-11-03 | ||
| PCT/EP2006/010258 WO2007051550A1 (en) | 2005-11-03 | 2006-10-25 | Oligopeptides and their use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013149195A Division JP5837539B2 (ja) | 2005-11-03 | 2013-07-18 | オリゴペプチドおよびその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009514906A JP2009514906A (ja) | 2009-04-09 |
| JP2009514906A5 true JP2009514906A5 (https=) | 2010-12-16 |
| JP5770965B2 JP5770965B2 (ja) | 2015-08-26 |
Family
ID=36371046
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008539289A Expired - Fee Related JP5770965B2 (ja) | 2005-11-03 | 2006-10-25 | オリゴペプチドおよびその使用 |
| JP2013149195A Expired - Fee Related JP5837539B2 (ja) | 2005-11-03 | 2013-07-18 | オリゴペプチドおよびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013149195A Expired - Fee Related JP5837539B2 (ja) | 2005-11-03 | 2013-07-18 | オリゴペプチドおよびその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US8101574B2 (https=) |
| EP (2) | EP1782819A1 (https=) |
| JP (2) | JP5770965B2 (https=) |
| KR (1) | KR101421742B1 (https=) |
| DE (1) | DE602006009296D1 (https=) |
| ES (1) | ES2332740T3 (https=) |
| WO (1) | WO2007051550A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1782819A1 (en) * | 2005-11-03 | 2007-05-09 | Cognis IP Management GmbH | Oligopeptides and their use |
| DE102009002285A1 (de) * | 2009-04-08 | 2010-10-14 | Henkel Ag & Co. Kgaa | Kopfhautschonende Shampoos und Conditioner |
| IT1407715B1 (it) * | 2010-06-18 | 2014-04-30 | Alphrema Srl | Composizioni ad uso topico per la profilassi ed il trattamento igienico di alcune problematiche di patologia ano-rettale, come emorroidi, ragadi, ascessi e fistole. |
| US9511144B2 (en) | 2013-03-14 | 2016-12-06 | The Proctor & Gamble Company | Cosmetic compositions and methods providing enhanced penetration of skin care actives |
| FR3012811B1 (fr) * | 2013-11-05 | 2015-12-25 | Basf Beauty Care Solutions France Sas | Oligopeptides et leurs utilisations |
| ITBS20130177A1 (it) * | 2013-11-27 | 2015-05-28 | Gianpaolo Pizzoli | Preparazione cosmetica |
| US20170281509A1 (en) * | 2014-09-12 | 2017-10-05 | Gojo Industries, Inc. | Compositions and methods for mitigating skin irritation |
| KR101851236B1 (ko) | 2015-07-06 | 2018-04-24 | 김철군 | 동충하초 재배용 배지조성물 및 동충하초 재배방법 |
| US20190248834A1 (en) * | 2016-06-27 | 2019-08-15 | Ruey J. Yu | Endomorphin-2, tetrapeptide derivatives thereof, and uses thereof |
| KR20190065916A (ko) | 2017-12-04 | 2019-06-12 | 김철군 | 동충하초 재배용 배지조성물 및 동충하초의 재배방법 |
| CN119143848B (zh) * | 2023-12-26 | 2025-11-25 | 杭州湃肽生化科技有限公司 | 环七肽-4及其制备方法及应用 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LU68901A1 (https=) | 1973-11-30 | 1975-08-20 | ||
| US4172887A (en) * | 1973-11-30 | 1979-10-30 | L'oreal | Hair conditioning compositions containing crosslinked polyaminopolyamides |
| NL8005121A (nl) | 1979-09-20 | 1981-03-24 | Erba Farmitalia | Biologisch actieve peptiden. |
| JPS6299315A (ja) * | 1985-10-25 | 1987-05-08 | Kanebo Ltd | 皮膚化粧料 |
| US5702688A (en) * | 1986-12-23 | 1997-12-30 | Tristrata Technology, Inc. | Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use |
| US4966848A (en) * | 1988-02-08 | 1990-10-30 | The General Hospital Corporation | Isolation, purification, characterization, cloning and sequencing of N α-acetyltransferase |
| US5223421A (en) * | 1989-10-25 | 1993-06-29 | The General Hospital Corporation | Identification of methionine Nα-acetyltransferase |
| SE9503924D0 (sv) | 1995-08-18 | 1995-11-07 | Astra Ab | Novel opioid peptides |
| IS4261A (is) | 1994-02-21 | 1995-08-22 | Astra Aktiebolag | Nýir peptíð-ópíóíðar til meðhöndlunar á verkjum og notkun þeirra |
| JPH0848695A (ja) * | 1994-08-05 | 1996-02-20 | Meito Sangyo Kk | ポルフイロモナス・ジンジバリスのタイプｉｉ線毛蛋白質の配列を含有するペプチド類及びその用途 |
| JPH08337537A (ja) * | 1995-06-15 | 1996-12-24 | Kao Corp | 細胞間接着阻害ペプチド |
| US5688489A (en) * | 1995-09-15 | 1997-11-18 | Resolution Pharmaceuticals, Inc. | Non-receptor mediated imaging agents |
| US5763576A (en) * | 1995-10-06 | 1998-06-09 | Georgia Tech Research Corp. | Tetrapeptide α-ketoamides |
| US5885958A (en) | 1997-03-25 | 1999-03-23 | Administrators Of The Tulane Educational Fund | Mu-opiate receptor peptides |
| JPH10330398A (ja) * | 1997-05-28 | 1998-12-15 | Asahi Glass Co Ltd | 新規環状ペプチド |
| DE19756377A1 (de) | 1997-12-18 | 1999-06-24 | Beiersdorf Ag | Verwendung von C¶1¶¶8¶-¶3¶¶8¶-Alkylhydroxystearoylstearat zur Verstärkung der UV-A-Schutzleistung kosmetischer oder dermatologischer Formulierungen |
| PL189753B1 (pl) * | 1998-11-12 | 2005-09-30 | Victor Hruby | Nowe pochodne peptydowe o aktywności przeciwbólowej oraz sposób ich otrzymywania |
| US6048902A (en) * | 1999-02-12 | 2000-04-11 | Lebwohl; Mark G. | Short contact treatment of psoriasis with topical retinoids |
| IL153359A0 (en) * | 2000-06-16 | 2003-07-06 | Hercules Inc | Peptides, compositions and methods for the treatment of burkholderia cepacia |
| WO2002010195A2 (en) * | 2000-08-02 | 2002-02-07 | Theratechnologies Inc. | Modified peptides with increased potency |
| US7148197B2 (en) * | 2000-08-24 | 2006-12-12 | The Regents Of The University Of California | Orally administered small peptides synergize statin activity |
| DE10106852A1 (de) * | 2001-02-14 | 2002-09-05 | T Luger | Entzündungshemmende Verbindungen |
| EP1427438A2 (en) | 2001-09-03 | 2004-06-16 | The University of Bristol | Inflammation modulatory compound comprising an endomorphin |
| JP2004175687A (ja) | 2002-11-25 | 2004-06-24 | Shiseido Co Ltd | 皮膚バリアー機能回復促進剤 |
| FR2857588B1 (fr) * | 2003-07-17 | 2007-11-30 | Oreal | Utilisation de beta-endorphine, d'agents exercant une activite beta-endorphine-like en cosmetique et dermatologie |
| EP1982997B1 (en) * | 2004-09-01 | 2012-08-08 | Allergan, Inc. | Degradable clostridial toxins |
| EP1782819A1 (en) * | 2005-11-03 | 2007-05-09 | Cognis IP Management GmbH | Oligopeptides and their use |
| WO2008056207A1 (en) * | 2006-11-08 | 2008-05-15 | Chongxi Yu | Transdermal delivery systems of peptides and related compounds |
| DE102009002286A1 (de) * | 2009-04-08 | 2010-02-11 | Henkel Ag & Co. Kgaa | Haarfärbe/wellmittel mit verbesserter Hautverträglichkeit |
| EP2427475B1 (en) * | 2009-05-08 | 2020-11-04 | Techfields Biochem Co., Ltd. | High penetration prodrug compositions of peptides and peptide-related compounds |
| WO2011146922A2 (en) * | 2010-05-21 | 2011-11-24 | Cytogel Pharma, Llc | Materials and methods for treatment of inflammation |
-
2005
- 2005-11-03 EP EP05023954A patent/EP1782819A1/en not_active Withdrawn
-
2006
- 2006-10-25 EP EP06806515A patent/EP1951276B1/en active Active
- 2006-10-25 ES ES06806515T patent/ES2332740T3/es active Active
- 2006-10-25 DE DE602006009296T patent/DE602006009296D1/de active Active
- 2006-10-25 JP JP2008539289A patent/JP5770965B2/ja not_active Expired - Fee Related
- 2006-10-25 WO PCT/EP2006/010258 patent/WO2007051550A1/en not_active Ceased
- 2006-10-25 KR KR1020087011525A patent/KR101421742B1/ko not_active Expired - Fee Related
- 2006-10-25 US US12/092,476 patent/US8101574B2/en active Active
-
2011
- 2011-12-16 US US13/328,684 patent/US8399415B2/en not_active Expired - Fee Related
-
2013
- 2013-07-18 JP JP2013149195A patent/JP5837539B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6674029B2 (ja) | 毛髪繊維特性を向上させるための組成物 | |
| JP2009514906A5 (https=) | ||
| JP5570977B2 (ja) | 桂皮酸またはアニス酸およびベンズアルデヒド（誘導体）を含む保存料非含有の組成物 | |
| JP2007302690A5 (https=) | ||
| NL2003786C2 (en) | COMPOSITION FOR TOPICAL APPLICATION, USES THEREOF, APPLICATOR DEVICE AND KIT OF PARTS. | |
| DK2190425T3 (en) | Topically applicable fungicidal agents for the treatment of nails | |
| JP2015525801A5 (https=) | ||
| JP2013515742A5 (https=) | ||
| JP5883886B2 (ja) | 抗真菌組成物 | |
| CN104010619A (zh) | 用于个人护理产品的抗微生物防腐剂组合物 | |
| CN113164361A (zh) | 个人护理组合物 | |
| KR20120015319A (ko) | 피부 및 손발톱의 진균 감염의 국소적 치료에 적절한 조성물 | |
| WO2020251017A1 (ja) | 外用剤組成物 | |
| JP6246812B2 (ja) | 口内洗浄剤及び歯過敏症治療組成物 | |
| WO2014078801A1 (en) | Methods and compositions comprising guanidines for treating biofilms | |
| CA2101083C (en) | Improved flexible collodion compositions | |
| US10258560B1 (en) | Composition for topical treatment of nail conditions | |
| JP2006045126A (ja) | フケ・痒み防止組成物 | |
| JP5081121B2 (ja) | 育毛剤組成物 | |
| FR3045352A1 (https=) | ||
| US20240156711A1 (en) | Pickering emulsions stabilized by cyclodextrin | |
| CN1142765C (zh) | 除臭剂组合物 | |
| EP3171942B1 (en) | Hair conditioning compositions | |
| WO2001070235A1 (fr) | Composition a base de sphingolipide et de beta-hydroxy-acide pour les soins de la peau | |
| JP2022544846A (ja) | 活性剤を局所的に送達するための溶媒送達システム |